Covered recipient · General Payments record
STANLEY X CAL
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2022–2024
$1,079.56
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $339.33 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $191.18 | 9 |
| Amgen Inc. | $65.14 | 4 |
| Exact Sciences Corporation | $38.11 | 2 |
| GlaxoSmithKline, LLC. | $16.42 | 1 |
| PFIZER INC. | $14.61 | 1 |
| DEXCOM, INC. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.98 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115476057 | CMS |
| Amgen Inc. | $20.24 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117519083 | CMS |
| Amgen Inc. | $13.73 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117519085 | CMS |
| Amgen Inc. | $16.19 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115476063 | CMS |
| Dexcom, Inc. | $13.87 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153337685 | CMS |
| Exact Sciences Corporation | $18.92 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114605095 | CMS |
| Exact Sciences Corporation | $19.19 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114605099 | CMS |
| GlaxoSmithKline, LLC. | $16.42 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116449009 | CMS |
| Lilly USA, LLC | $18.33 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135424327 | CMS |
| Lilly USA, LLC | $13.18 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135411557 | CMS |
| Lilly USA, LLC | $11.99 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430857 | CMS |
| Lilly USA, LLC | $17.63 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430859 | CMS |
| Lilly USA, LLC | $4.67 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135411559 | CMS |
| Lilly USA, LLC | $2.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349673 | CMS |
| Lilly USA, LLC | $18.75 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135411561 | CMS |
| Lilly USA, LLC | $14.70 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135429559 | CMS |
| Lilly USA, LLC | $89.78 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135429561 | CMS |
| PFIZER INC. | $14.61 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131827590 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.